JA

JASPER BIOTECHNOLOGY CO., LIMITED

傑森拜爾生物科技有限公司

Health & Medical
Follow

General Information

Official company information

Business Registration (BR) Number
75969027
Company Registration Number
3343800
Company Age
1 year
Registration Date
Registered Address
香港 灣仔駱克道315-321號 駱基中心(大廈)23樓C室
Email
N/A

About JASPER BIOTECHNOLOGY CO., LIMITED

Company profile and description

Jasper is a biotechnology company focused on targeting mast cells to treat chronic mast cell diseases. They are developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) for treating chronic mast diseases such as chronic urticaria and asthma. Jasper is currently conducting clinical studies of briquilimab in patients with chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU) and planning a study for asthma. Briquilimab has demonstrated efficacy and safety in over 160 dosed subjects and healthy volunteers.

Category

Business category and classification details

Primary Category
Health & Medical
Description
Providers of medical, dental, therapeutic, and other health-related services, including hospitals, clinics, private practices, and pharmacies.

Additional Information

Detailed company information and status

Company Type
Private company limited by shares
Location Code
HK
Company Origin
Local Company
Registration Status
Active

Company Contacts

Key contacts and leadership

Name & Position Email Contact Number Fax Number

Request For Information Free

We will attempt to gather this information through our sources

Current requests: 0

Similar Companies

Companies in the same industry or category

View All in Health & Medical

In the News

Recent media coverage and press mentions

No recent media coverage

No recent news articles found for JASPER BIOTECHNOLOGY CO., LIMITED

Social Media

Connect with JASPER BIOTECHNOLOGY CO., LIMITED

No social media links available